Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Frontline Therapy for Transplant Ineligible Patients with MM
Videos
Frontline Therapy for Transplant Ineligible Patients with MM
03/07/2020
Keith Stewart, MD, ChB, discusses treatment options for newly diagnosed patients with myeloma ineligible for transplant.
Keith Stewart, MD, ChB, discusses treatment options for newly diagnosed patients with myeloma ineligible for transplant.
Keith Stewart, MD, ChB,...
03/07/2020
Oncology
Videos
Michael R. Savona, MD, Discusses Diagnosis and Treatment Options for CMML
06/27/2019
Michael R. Savona, MD, explains some of the challenges with diagnosing chronic myelomonocytic leukemia (CMML) and treatment options that are currently available and being studied for these patients.
Michael R. Savona, MD, explains some of the challenges with diagnosing chronic myelomonocytic leukemia (CMML) and treatment options that are currently available and being studied for these patients.
Michael R. Savona, MD, explains...
06/27/2019
Oncology
Videos
Jacqueline C. Barrientos, MD, MS, Explains the Rationale for Using Combination Therapies in CLL
06/18/2019
Jacqueline C. Barrientos, MD, MS, explains why combining therapies is beneficial for the treatment of patients with CLL.
Jacqueline C. Barrientos, MD, MS, explains why combining therapies is beneficial for the treatment of patients with CLL.
Jacqueline C. Barrientos, MD,...
06/18/2019
Oncology
Videos
MRD Assessment in Patients With Multiple Myeloma
05/09/2019
Thomas G. Martin, MD, discusses MRD assessment in patients with multiple myeloma and how it may be able to influence therapy selection for these patients.
Thomas G. Martin, MD, discusses MRD assessment in patients with multiple myeloma and how it may be able to influence therapy selection for these patients.
Thomas G. Martin, MD, discusses...
05/09/2019
Oncology
Videos
New Therapies Making a Big Impact in ALL
04/08/2019
Daniel A. Pollyea, MD, MS, discusses novel therapies for ALL and how they are changing clinical practice.
Daniel A. Pollyea, MD, MS, discusses novel therapies for ALL and how they are changing clinical practice.
Daniel A. Pollyea, MD, MS,...
04/08/2019
Oncology
Videos
The Importance of Sequencing Monotherapy in CLL
04/06/2019
Jacqueline C. Barrientos, MD, MS, explains the importance of sequencing monotherapy in chronic lymphocytic leukemia.
Jacqueline C. Barrientos, MD, MS, explains the importance of sequencing monotherapy in chronic lymphocytic leukemia.
Jacqueline C. Barrientos, MD,...
04/06/2019
Oncology
Videos
Richard R. Furman, MD, Discusses Ibrutinib Versus FCR for Patients With CLL
04/06/2019
Richard R. Furman, MD, discusses ibrutinib compared with the standard chemoimmunotherapeutic regimen of intravenous fludarabine, cyclophosphamide, and rituximab, for patients with CLL.
Richard R. Furman, MD, discusses ibrutinib compared with the standard chemoimmunotherapeutic regimen of intravenous fludarabine, cyclophosphamide, and rituximab, for patients with CLL.
Richard R. Furman, MD, discusses...
04/06/2019
Oncology
Videos
Emerging Immunotherapies and the Future of Multiple Myeloma Treatment
04/05/2019
Thomas G. Martin, MD, discusses promising immunotherapies in the pipeline for multiple myeloma and how they will affect the future treatment of this disease.
Thomas G. Martin, MD, discusses promising immunotherapies in the pipeline for multiple myeloma and how they will affect the future treatment of this disease.
Thomas G. Martin, MD, discusses...
04/05/2019
Oncology
Videos
Influx of New Therapies Exciting for Future of AML Treatment
03/23/2019
Daniel A. Pollyea, MD, MS, discusses all the recent drug approvals in AML and how they are changing clinical practice.
Daniel A. Pollyea, MD, MS, discusses all the recent drug approvals in AML and how they are changing clinical practice.
Daniel A. Pollyea, MD, MS,...
03/23/2019
Oncology
Videos
When to Consider Second Autologous Transplant for Patients With Relapsed Multiple Myeloma
03/22/2019
Andrew J. Cowan, MD, explains when physicians should consider a second autologous stem cell transplant for patients with relapsed multiple myeloma.
Andrew J. Cowan, MD, explains when physicians should consider a second autologous stem cell transplant for patients with relapsed multiple myeloma.
Andrew J. Cowan, MD, explains...
03/22/2019
Oncology

Advertisement

About

At Great Debates and Updates in Hematologic Malignancies, nationally recognized thought leaders take opposing sides on clinical—and sometimes controversial—topics currently disrupting the practice of hematology and oncology.

Through comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.

Platinum Sponsors

johnson & johnson

 

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use